The Insulin in Dosage Market Size Value Per Capita in Australia experienced fluctuations over the period from 2012 to 2022. The peak value was in 2013 at 31.58, followed by a decline in subsequent years with mild recoveries. The lowest point was in 2022 with a value of 21.63. Significant year-on-year variations were notable, especially the drop from 2013 to 2014 and 2015 to 2016. Over the last two years, a slight decline from 2021 to 2022 was observed. The Compound Annual Growth Rate (CAGR) over the last five years indicated an average annual decline, reflecting a shrinking market size.
Future trends to watch for include the impact of advancements in insulin delivery technologies and government healthcare policies on market dynamics. Additionally, the growing prevalence of diabetes and potential changes in pricing strategies by pharmaceutical companies could influence the market trajectory in the coming years.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 6 | 6 Australia | 21.27 | 2023 | |||
| 7 | 7 Croatia | 21.13 | 2023 | View data | ||
| 8 | 8 Italy | 20.63 | 2023 | View data | ||
